Her-2/neu oncogene amplification in clinically localised prostate cancer.
暂无分享,去创建一个
J. Oxley | D. Gillatt | M. Winkler | D. Peat
[1] E. Frenkel,et al. Laboratory assessment of the status of Her-2/neu protein and oncogene in breast cancer specimens: comparison of immunohistochemistry assay with fluorescence in situ hybridisation assays , 2000, Journal of clinical pathology.
[2] C. Cordon-Cardo,et al. Response of prostate cancer to anti-Her-2/neu antibody in androgen-dependent and -independent human xenograft models. , 1999, Cancer research.
[3] H. Mark,et al. Fluorescence in situ hybridization study of HER-2/neu oncogene amplification in prostate cancer. , 1999 .
[4] J. Oxley,et al. Preoperative p53, bcl-2, CD44 and E-cadherin immunohistochemistry as predictors of biochemical relapse after radical prostatectomy. , 1999, The Journal of urology.
[5] J. Coebergh,et al. Striking increase in incidence of prostate cancer in men aged < 60 years without improvement in prognosis , 1999, British Journal of Cancer.
[6] Holger Moch,et al. Advances in Brief Survey of Gene Amplifications during Prostate Cancer Progression by High-Throughput Fluorescence in Situ Hybridization on Tissue Microarrays 1 , 1999 .
[7] J. Ross,et al. Correlation of p34cdc2 cyclin-dependent kinase overexpression, CD44s downregulation, and HER-2/neu oncogene amplification with recurrence in prostatic adenocarcinomas. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[8] C. Sheehan,et al. HER-2/neu gene amplification status in prostate cancer by fluorescence in situ hybridization. , 1997, Human pathology.
[9] J. Ross,et al. Prognostic significance of HER‐2/neu gene amplification status by fluorescence in Situ hybridization of prostate carcinoma , 1997, Cancer.
[10] M. Rifkin,et al. Contribution of HER‐2/neu oncogene expression to tumor grade and DNA content analysis in the prediction of prostatic carcinoma metastasis , 1993, Cancer.
[11] J. Moul,et al. Expression of the c-erbB-2 (HER-2/neu) oncoprotein in human prostatic carcinoma. , 1993, The Journal of urology.
[12] G. Miller,et al. Expression of c‐erb B‐2/neu proto‐oncogene in human prostatic cancer tissues and cell lines , 1992, Molecular carcinogenesis.